Table 3

Clinical measures
Parameter Jiangtang Xiaozhi Placebo P
Baseline Week 16 Baseline Week 16
Fasting blood glucose (mmol/L) 6.3 ± 0.9 6.3 ± 1.1 6.7 ± 1.0 6.7 ± 1.3 0.70
Postprandial blood glucose (mmol/L) 10.45 ± 2.3 9.66 ± 2.6* 10.98 ± 2.9 10.60 ± 3.4 0.51
HbA1c (%) 6.4 ± 0.7 6.5 ± 0.7 6.3 ± 0.6 6.4 ± 0.6 0.62
Insulin (mmol/L) 11.8 ± 6.9 11.6 ± 5.5 15.5 ± 9.7 22.1 ± 25.9 0.04
HOMA-IR 1.63 ± 0.91 1.58 ± 0.74 2.06 ± 1.28 2.43 ± 1.59 0.06
HOMA%B 81.52 ± 34.5 83.5 ± 38.1 86.51 ± 36.78 98.83 ± 48.29 0.26
HOMA%S 81.84 ± 48.12 79.72 ± 44.14 72.78 ± 46.42 62.67 ± 38.48 0.34
Total cholesterol (mmol/L) 4.91 ± 1.03 4.96 ± 0.94 4.47 ± 0.85 4.56 ± 0.81 0.46
HDL cholesterol (mmol/L) 1.45 ± 0.44 1.54 ± 0.53 1.28 ± 0.30 1.24 ± 0.30 0.03
Triglycerides (mmol/L) 1.6 ± 0.64 1.6 ± 0.76 1.67 ± 0.93 1.59 ± 0.86 0.92
C-reactive protein (mg/L) 6.7 ± 7.6 4.66 ± 1.77 6.73 ± 5.25 5.18 ± 3.0 0.36
Weight (kg) 80.5 ± 15.1 80.4 ± 15.0 92.0 ± 28.5 91.8 ± 28.6 0.84
BMI (kg/m2) 29.8 ± 4.9 31.0 ± 1.8 32.0 ± 8.0 31.2 ± 1.8 0.64
Waist (cm) 97.6 ± 11.1 98.6 ± 12.4 109.9 ± 22.1 106.3 ± 18.6 0.05
Systolic blood pressure (mmHg) 124.5 ± 13.3 124.1 ± 15.5 134.4 ± 14.0 130.1 ± 16.1 0.96
Diastolic blood pressure (mmHg) 76.4 ± 11.1 71.7 ± 8.6 81.7 ± 74.3 74.3 ± 2.2 0.96

All data are means ± SD unless otherwise stated.

*within group statistically significant.

Grant et al.

Grant et al. BMC Complementary and Alternative Medicine 2013 13:104   doi:10.1186/1472-6882-13-104

Open Data